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E-mail: S.Seyedmousavi@gmail.comIntroductionDepending on the source of infections, zoonoses are
described as infectious diseases that can be naturally trans-
mitted between vertebrate animals and man [1]. The causative
agent may be a bacterium, a virus, an ectoparasite, a helminth,
a protozoa, or a fungus [2]. An animal can be either reservoir
or mechanical vector of zoonotic pathogens, therefore the
transmission may be direct or indirect [3]. In most cases, many
wild and domesticated animals (including their faeces and soil
in their burrows) play an essential role in maintaining the
infection in nature and contribute in varying degrees to the
distribution and actual transmission of infection in human andMicrobiol Infect 2015; 21: 416–425
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.02.031animal populations [4]. Although zoonotic agents can be
transmitted from an infected host to others, inter-human
transfer is uncommon.
From a global prospective, zoonotic infections have been
recognized for many centuries, and account for the majority of
emerging and re-emerging infectious diseases, worldwide [5,6].
It has been shown that zoonoses occur due to increased con-
tact between humans and animals as a by-product of develop-
ment, industrialization and encroachment on wildlife habitats,
resulting in a dynamic upward trajectory of these diseases [7].
Fungal infections associated with zoonotic and or sapronotic
transmission are an important public health problem worldwide
[8]. A number of these infections are among the group of the most
common fungal diseases, such as: dermatophytosis [9], sporotri-
chosis [10,11] and histoplasmosis [12]. Within this context, it is
however notable that some fungal diseases with zoonotic potential
have lacked adequate attention in international public health ef-
forts, leading to insufﬁcient attentionon their preventive strategies.
In this paper, we provide an overview of neglected fungal
pathogens that could be carried and transmitted betweenious Diseases. Published by Elsevier Ltd. All rights reserved
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ogy and geographical distribution, current epidemiology, type of
diseases in humans and animals, source of infection and mode of
transmission will be discussed.Fungal zoonoses versus sapronosesFrom an evolutionary viewpoint, mycotic infectious agents can
be either true pathogens or opportunists [13], and from the same
perspective pathogens can be divided into environmental path-
ogens (having a saprobic but infectious phase in the environment)
and obligatory pathogens (having host-to-host transmission).
Systemic environmental pathogenic fungi may produce invasive
forms in infected tissue, such as the spherule in Coccidioides or
intracellular yeast in Histoplasma [12]. Nearly all fungi are able to
thrive in the environment for extended periods, but pathogens
have an evolutionary advantage of the use of a vertebrate vector
during a part of their life cycle. Often an animal other than
humans is the prime target of the fungus, with humans as non-
optimal hosts. Infections originating from an animal are termed
zoonoses [1]. The clinical course of systemic pathogens can be
fatal in hosts with severe impairment of acquired immunity, but in
healthy hosts the infection is often relatively mild.
In contrast, opportunistic fungi have a preferred habitat in-
dependent from the living hosts [13]. Factors enabling survival
in human tissue are purely coincidental. Infections may never-
theless occur repeatedly from a single source, and we then
speak of sapronoses [14]. Infection of the non-preferred human
host decreases ﬁtness of the fungus. The fungus is poorly
adapted to this unexpected habitat and therefore may provoke
a strongly inﬂammatory response, which in patients with severe
impairment of their innate cellular immunity may be fatal.
Table 1 shows the list of clinically signiﬁcant fungi with
zoonotic potential that can cause considerable medical, veter-
inary and/or public health problems. Some of these fungi and
corresponding infections have been extensively investigated in
the literature [8–12,15–17]. Here we discuss the fungal path-
ogens whose zoonotic potential is neglected, including: Talar-
omyces (Penicillium) marneffei, Lacazia loboi, Emmonsia spp.,
Conidiobolus spp., Basidiobolus ranarum and Paracoccidioides
brasiliensis.PenicilliosisPenicilliosis is caused by the emerging pathogenic fungus Peni-
cillium marneffei that usually causes a fatal disseminated disease
in immunocompromised individuals, especially those with hu-
man immunodeﬁciency virus (HIV) infection [18]. PenicilliumClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologymarneffei is a dimorphic fungus exhibiting a mycelial form at 25°
C and a yeast form at 37°C. Upon tissue invasion, P. marneffei
undergoes a morphological phase transition from saprobic
mould to yeast form that capably evades the host immune
system [19]. For phylogenetic reasons the fungus was renamed
as Talaromyces marneffei, underlining its remote distance to
saprobic Penicillium species [20,21].
Ecology and source of infection
The fungus may have a natural habitat in soil in areas of
southern China and South-East Asia where it is endemic
[18,22]. Talaromyces marneffei was originally isolated from the
bamboo rat, Rhizomys sinensis, in 1956 [19]. Since then, addi-
tional studies demonstrated that three other bamboo rat spe-
cies may act as reservoirs: Rhizomys pruinosus, Rhizomys
sumatrensis and the reddish-brown subspecies of Cannomys
badius. Within these rodent species, the prevalence of infection
varies widely across South-East Asia [23,24]. In addition, more
recently, dogs have been suggested as a possible reservoir for
T. marneffei [25].
Epidemiology in humans
The infection is recognized as an AIDS-deﬁning opportunistic
infection [26,27] in regions where the fungus is endemic. In
Thailand Chiang Mai province, it is the third most common
HIV-related opportunistic infection (after tuberculosis and
cryptococcosis) [18,27,28]. Penicilliosis affects all ages and both
sexes, although 90% of the cases reported in the literature are
male [29]. Notably, the risk of infection is not restricted to
those living in areas where it is endemic. HIV-infected in-
dividuals who travelled to areas of endemicity have also become
infected by T. marneffei [30]. Of note, the mortality rate of
untreated T. marneffei infections in HIV-infected patients is
100% [31].
Disease in humans
In patients who are not immunocompromised, most cases of
penicilliosis show generalized lymphadenopathy, fever, weight
loss, anaemia and a non-productive cough, which may strongly
resemble histoplasmosis, cryptococcosis and tuberculosis [32].
In HIV-infected patients, the disease is usually disseminated,
affecting skin, reticuloendothelial system, lung and gut. Other
tissues can be involved in the disease such as liver, spleen, skin
and mucosa, which are the most commonly affected tissues. In
contrast to histoplasmosis and tuberculosis, adrenal involve-
ment and central nervous system infections are uncommon.
The molluscum contagiosum-like lesions of skin and mucosa
indicate disseminated disease [29]. Most patients acquire skin
lesions on the face and neck. Chest radiographs show patchy
inﬁltration and sometimes abscess formation.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 416–425
TABLE 1. Medically important fungi with the potential of zoonotic transmission to humans
Aetiological agent Disease Known distribution
Probable means of
transmission to
humans Target animals
Clinical signs of disease in
animals Clinical signs of disease in human
Microsporum spp.,
Trichophyton spp.
Dermatophytosis Worldwide Direct contact with
infected animals or
material
All domesticated
mammals and
sometimes wildlife
Classical ring lesion with central
healing and crusts at the
peripheral area, some degree
of folliculitis
Tinea capitis, Tinea barbae, Tinea faciei, Tinea
corporis, Tinea cruris, Tinea ungium, Tinea
pedis, Tinea manum, Tinea
Sporothrix schenckii
Sporothix brasiliensis
Sporotrichosis Worldwide Work-related trauma,
scratches or bites
from animals
Cats; occasionally
dogs, horse, cow,
camel, dolphin, goat,
mule, bird, pig, rat,
armadillo
Localized cutaneous,
lymphocutaneous and
disseminated infection
Fixed cutaneous, lymphocutaneous,
osteoarticular and disseminated infection
Mallasezia spp. Malassezia infection
(pityriasis)
Worldwide Malassezia yeasts are
commensal of
human skin (part of
the normal
microbiota)
Domestic animals such
as dogs, cats, cows,
sheep, pig, horse,
wild animals held in
captivity, and
animals from wildlife
Dermatitis, alopecia, stenosis,
otitis externa
Chronic superﬁcial disease of the skin
(pityriasis versicolor), folliculitis,
seborrhoeic dermatitis and dandruff,
fungaemia
Cryptococcus neoformans,
Cryptococcus gattii
Cryptococcosis Worldwide Mainly by inhalation od
fungus, occasionally
through breaks in
the skin
Wide variety of
mammals, birds,
reptiles and
amphibians
Focal or disseminated infection,
affecting a single organ system
or many, central nervous
system involvement
Cutaneous, ocular, pulmonary and central
nervous system involvement
Penicillium (Talaromyces)
marneffei
Penicilliosis Southern China
and South-East Asia
Unknown Bamboo rats, domestic
animals such as
dogs, cats
Skin dermatitidis, rhinitis, otitis
externa and disseminated
infection
Non-speciﬁc clinical signs (generalized
lymphadenopathy, molluscum contagiosum-
like lesions of the skin and mucosa) and
disseminated infection
Lacazia loboi Lobomycosis South and Central
America, United States,
Canada, Europe,
South Africa
Trauma Dolphins Granulomatous dermatitis Granulomatous dermatitis
Emmonsia spp. Adiaspiromycosis Case reports from Asia,
Australia, Europe,
North America
Inhalation of the fungus Wild rodents Deep mycoses Lung and disseminated disease
Conidiobolus coronatus,
Conidiobolus incongruus,
Basidiobolus ranarum
Entomophthoromycosis Tropical countries of Africa,
Asia, United States
and Europe
Traumatic
implantation or
inhalation of the
fungus
Horses, dogs, sheep Cutaneous and disseminated
infection
Chronic subcutaneous and invasive infection
Histoplasma capsulatum Histoplasmosis Worldwide (endemic in
Mississippi and Ohio
River valleys in USA)
Inhalation of the fungus Cattle, sheep, horses Non-speciﬁc signs (chronic
gastrointestinal infection) and
disseminated infection
Chronic progressive lung disease, chronic
cutaneous or systemic disease or an acute
fulminating fatal systemic disease
Coccidioides immitis,
Coccidioides posadasii
Coccidioidomycosis Southwestern USA,
northern Mexico,
Central and South America
Inhalation of
arthroconidia and
skin trauma
Dogs, llamas, non-
human primates,
cats, horses,
domesticated or
wild mammals,
snakes
Asymptomatic to severe and
fatal infection
Cutaneous, pulmonary, disseminated infection
Paracoccidioides brasiliensis,
Paracoccidioides lutzii
Paracoccidioidomycosis South America Inhalation of the
fungus, injuries of
the skin and mucosal
membranes
Dogs, domesticated
and wild animals
(armadillos and
monkeys)
Non-speciﬁc clinical signs
depending on the organ
involved (lymphadenomegaly,
apathy, and
hepatosplenomegaly)
Mucocutaneous, pulmonary or disseminated
infection
Blastomyces dermatitidis Blastomycosis Worldwide (endemic in
North American continent,
autochthonous in Africa,
South America and Asia
Inhalation of airborne
conidia
Dogs, cats, horses,
marine mammals
Cutaneous, pulmonary, systemic
infection
Cutaneous, pulmonary, disseminated infection
(granulomatous and suppurative lesions in
lung, skin and bones)
Pneumocystis carinii (mammals),
Pneumocystis jirovecii (Human)
Pneumocystosis Worldwide Inhalation of airborne
conidia
Rodents, dogs, cats,
cattle
Lethal pneumonia in immune
debilitated animals
Asymptomatic, interstitial pneumonia,
progressive pneumonia (in
immunocompromised hosts)
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Penicilliosis is a rare infection in domestic animals such as dogs
and cats [25]. Clinical signs of infection include skin dermatitis,
rhinitis and otitis externa [33]. Symptomatic animals have nasal
discharge and ulceration of external nares and epistaxis. How-
ever, up to 40% of seemingly normal dogs will have a nasal swab
positive for T. marneffei on culture [25]. In addition, disseminated
infections have been reported in dogs, with peripheral lymph-
adenopathy [34] and bronchopneumonia [35]. No clinical signs
have been reported in naturally infected bamboo rats [20]. The
prevalence of infection varies widely across South-East Asia,
suggesting that there are regional variations in the endemicity of
infection or there are geographical variations in the predisposi-
tion to infection within different species of bamboo rats [18].
Mode of transmission
A lot is still unknown about the natural reservoir and route of
transmission of T. marneffei. While bamboo rats are a natural
reservoir, they are generally not in close contact with humans
and there is no evidence of direct transmission from rats to
humans [25]. However, bamboo rats and HIV-positive patients
have been found to share genetically similar strains of
T. marneffei, suggesting that rat-to-human transmission might be
possible or co-infection from a common but still unidentiﬁed
source [36]. Infected rats appear healthy [24]. In addition,
recent studies suggested that domestic animals such as dogs
might be another possible reservoir for T. marneffei in the re-
gions where it is endemic [25]. To date T. marneffei has never
been recovered from environments other than those that are
intimately associated with bamboo rats.LobomycosisLobomycosis is a rare chronic, granulomatous, fungal infection of
the skin and subcutaneous tissues [37,38]. Despite important
advances having been made through the use of updated molecular
biology techniques, the aetiological agent of lobomycosis has never
been cultured and grown in vitro. In 1999, Taborda et al. proposed
the agent in a new genus, Lacazia, calling it Lacazia loboi [39].
Ecology and source of infection
Soil and vegetation are believed to be the chief habitat of the
fungus. However, increasing reports of the disease in aquatic
mammals such as the dolphin has shifted attention to water and
the aquatic environment [38,40].
Epidemiology in humans
The disease has been diagnosed generally in tropical areas with
an average temperature of 24°C and relative humidity higherClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologythan 75% [41]. The calculated prevalence of lobomycosis is
3.05/10 000 inhabitants in the Amazon region of Brazil [42,43].
Most patients diagnosed have been in the Amazon basin and
countries of South and Central America [44]. There have also
been imported cases in the USA, Canada, Europe and South
Africa [38].
Disease in humans
Lobomycosis does not affect the general health of the patient
[43]. Patients often report a bite or sting from an arthropod,
snake or stingray, or trauma from a cutting instrument. The
clinical manifestations of lobomycosis are pleomorphic lesions,
dermal nodules, either lenticular or in plaques, which can be
either hyperpigmented or hypopigmented (Fig. 1). The lesions
are generally painless, although pruritus and dysaesthesia have
been occasionally described. The cheloid-like lesions can
resemble nodular leprosy or leishmaniasis, or other subcu-
taneous mycoses (sporotrichosis, chromomycosis, para-
coccidioidomycosis), cheloids and malignant tumours [37].
Disease in animals
Lobomycoses have been described in two species of dolphins
(Delphinidae): the common bottlenose dolphin (Tursiops trun-
catus) from the Atlantic coast of the USA and Europe, and the
Guyana dolphin (Sotalia guianensis) from the Surinam River es-
tuary [45]. The lesions are characterized by greyish, white to
pink verrucous lesions that may ulcerate and form large plaques
(Fig. 2) [46]. The disease progresses over years and may
disﬁgure large areas of the body [38]. The prevalence of
lobomycosis in bottlenose dolphins of Florida is reported to be
6.8% [47].
Mode of transmission
The possibility of zoonotic transmission of this disease is still
under investigation. However, it is highly probable that the
transmission occurs by direct contact with infected animals
following abrasion or trauma of the skin [40]. Lobomycosis
can be transmitted directly from human-to-human under
accidental circumstances [48]. Dolphin-to-human transmission
of lobomycosis has also been reported in an aquarium
attendant who had had close physical contact with an affected
dolphin [49].AdiaspiromycosisAdiaspiromycosis is a rare chronic pulmonary infection caused
by dimorphic fungi from the genus Emmonsia within the family
Ajellomycetaceae [50–52]. The infection is characterized by
the presence of very large adiaspores in the lungs [53]. Inhaledand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 416–425
FIG. 1. Clinical manifestations and laboratory features of lobomycosis in humans. Reproduced from reference Paniz-Mondolﬁ et al. 2012 [38] with
permission of the publisher. Keloid-like lesions over the upper limb of a patient with lobomycosis (a); multiple conﬂuent papules, plaques and nodule
lesions admixed with small verrucous areas on the foot of a patient with lobomycosis (b, c); Grocott methamine silver-stained section showing multiple
isolated and chained yeasts (magniﬁcation × 40) (d).
420 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIconidia of Emmonsia produced from the mycelial phase growing
at ambient temperatures fail to germinate in the lung, and
instead simply increase in volume to form thick-walled, non-
replicating adiaspores [54].FIG. 2. Clinical manifestations and laboratory features of lobomycosis in a do
permission of the publisher. Extensive white greyish proliferating lesions with
(b) and ﬁn (c) of a dolphin; Grocott methamine silver-stained section from a sk
and in chains connected by thin tubular bridges (magniﬁcation ×400) (d).
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectCurrently, two species of Emmonsia are known as main
agents of pulmonary diseases in human and animals:
Emmonsia crescens and Emmonsia parva [51]. However, a new
species, ‘Emmonsia pasteuriana’, has been recently describedlphin. Reproduced from reference Paniz-Mondolﬁ et al. 2012 [38] with
keloidal and verrucous aspect forming rosettes on the dorsal (a), ﬂanks
in biopsy specimen of a dolphin showing abundant yeast cells individually
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 416–425
CMI Seyedmousavi et al. Neglected fungal zoonoses 421causing disseminated cutaneous infection in HIV-infected
patients [55].
Ecology and source of infection
Emmonsia species are commonly found in soil but also occur in
mammalian species living in close association with soils such as
rodents, insectivores, otters, stoats, weasels, moles and ground
squirrels [56]. Among species in this genus, E. crescens is
widespread in continental Europe and UK, whereas E. parva is
found mainly in some xerothermic regions, including parts of
the Americas, Central Asia and Africa [56].
Epidemiology in humans
In humans, adiaspiromycosis is a rare pulmonary infection.
Disseminated pulmonary adiaspiromycosis can progress to
respiratory failure and death; however, mortality rates are low
[53]. There are nearly 200 reports of Emmonsia infections in
human lungs and less than 20 (sub)cutaneous infections in the
literature [53].
Disease in humans
Cases of human infection are rare and primarily pulmonary
conditions similar to that observed in animals, with only a few
cases of infection at other sites [53]. The disease is usually
localized, asymptomatic and self-limited; however, disseminated
fatal cases have been reported [54]. The severity of the adias-
piromycosis in humans depends on the amount of the airborne
conidial burden inhaled and host immunocompetence, and
range from asymptomatic infection through necrogranuloma-
tous pneumonia and even death [54].
Disease in animals
Emmonsia species have an extremely broad host range and
infections have been reported in many species of small
mammals, worldwide [56,57]. Histopathological examination
of the infected animals generally reveals a multifocal extensive
granulomatous reaction containing oval adiaspores scattered
irregularly throughout the lungs [57]. The frequency of
infected animals varies according to geographic area, altitude,
habitat, and season. Several studies clearly indicated that
almost 30% of all small wild mammals examined in the UK
and parts of central and eastern Europe where it is endemic,
had evidence of infection [57], raising the possibility that
sporadic infections might also occur in domestic animals and
humans [56].
Mode of transmission
Similar to other dimorphic onygenalean fungi, Emmonsia species
are environmental pathogens, having a life cycle involving soil
and vectoring by the animals [50].Clinical Microbiology and Infection © 2015 European Society of Clinical MicrobiologyEntomophthoromycosisEntomophthoromycosis is a chronic subcutaneous infection
caused by zygomycetes of the order Entomophthorales: Con-
idiobolus coronatus, Conidiobolus incongruus and Basidiobolus
ranarum [58].
Ecology and source of infection
Both Conidiobolus spp. and B. ranarum are generally considered
as saprobe distributed in plant debris and soil of tropical areas
[59]. In addition, these fungi are present as a commensals in the
gastrointestinal tract of amphibians, ﬁsh, reptiles and insectiv-
orous bats [60].
Epidemiology in humans
The disease occurs sporadically as a result of traumatic im-
plantation or inhalation of the fungus that is present in plant
debris in tropical environments. Both types of entomophthor-
omycosis are reported in tropical countries of Africa, Asia, USA
and Europe [58]. Gastrointestinal basidiobolomycosis has a 20%
mortality rate despite all of the therapeutic measures [61,62].
Disease in humans
Typically, B. ranarum causes subcutaneous infection in immu-
nocompetent young adults and rarely involves the gastrointes-
tinal tract [61]. Human infection with Conidiobolus species
occurs predominately as chronic rhinofacial mycosis in other-
wise healthy hosts [59]. In addition, invasive con-
idiobolomycosis has been reported in immunocompromised
patients that can cause endocarditis and widespread fatal
dissemination [63].
Disease in animals
Conidiobolomycosis is reported mainly in horses [64], sheep
[65,66] and dogs [67]. Ulcerative pyogranulomatous lesions of
the mucosa of the nasopharyngeal tissue, mouth or nodular
growths of the nasal mucosa and the lips may be seen with
conidiobolomycosis, similar to those caused by pythiosis and
lagenidiosis. Disseminated basidiobolomycosis is rare but has
been described in dogs and mandrills [68].
Mode of transmission
The transmission dynamics of these fungi is still under investi-
gation. However, the isolation of Conidiobolus spp. and
B. ranarum from reptiles, amphibians and ﬁsh, and infection in
various animals, strongly suggest interspeciﬁc transmission [8].
Infection due to B. ranarum is thought to occur following
traumatic implantation of the fungus into the subcutaneous
tissues. Infections with Conidiobolus spp. occur followingand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 416–425
422 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIinhalation of the fungal spores, which then germinate and
induce the invasion of nasal cavity, paranasal sinuses and facial
soft tissues.ParacoccidioidomycosisParacoccidioidomycosis is an acute to chronic systemic infec-
tion caused by a thermally dimorphic fungus, Paracoccidioides
brasiliensis [12,69] and its relative Paracoccidioides lutzii.
Ecology and source of infection
The natural habitat of P. brasiliensis, its environmental niche and
life cycle in nature remain unknown, but it is presumed that the
fungus is able to survive and proliferate in the soil [69]. The
fungus generally enters via the respiratory tract or injuries of
the skin and mucosal membranes [70].
Epidemiology in humans
Paracoccidioidomycosis is considered to be the third leading
cause of death from chronic infectious disease in South America,
and the mortality rate for paracoccidioidomycosis is 1.65 cases/
1 000 000 population [71]. It is endemic in the AmericanFIG. 3. Clinical manifestations and laboratory features of paracoccidioidomyco
permission of the publisher. Ulcerative lesion with punctate haemorrhagic dot
plaques, some of which are beginning to ulcerate (b); centrofacial cutaneou
bilateral nodular opacities in pulmonary Paracoccidioidomycosis (d); direct mic
with thick bi-refringent walls (magniﬁcation × 40) (e); splenic tissue showing
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectcontinent, and the highest incidence of the disease was regis-
tered in South American countries including Brazil, Argentina,
Colombia and Venezuela [72]. However, cases outside of the
areas of endemicity continue to be described, in general with
long periods of latency, representing endogenous reactivations
of the infectious focus previously acquired in endemic regions
[73]. The annual prevalence of the disease in areas where it is
endemic ranges from three or four new cases/1 000 000 pop-
ulation to one to three new cases/100 000 population. Most
patients are males (>90%), agricultural workers, often
malnourished, and usually 30–60 years of age [12,72].
Disease in humans
Following inhalation, P. brasiliensis typically causes asymptomatic
chronic pulmonary infection that disseminates as ulcerative
granulomata in the mucosal surfaces of the nose, mouth and
gastrointestinal tract [69]. In addition to the skin and lymph
nodes, the infection may spread to internal organs [12,72].
Symptomatic cases may develop an acute and or sub-acute or
chronic pneumonia with clinical features resembling tubercu-
losis (Fig. 3) [12]. This form of infection is almost always
observed in children, adolescents, and adults <30 years of age,
and represents <10% of the cases [69,72,74].sis in humans. Reproduced from reference Ameen et al. 2010 [72] with
s (a); dissemination to the skin, presenting as erythematous papules and
s and mucosal ulcerative lesions (c); chest radiograph depicting diffuse
roscopy of a skin scraping detects fungal cells of paracoccidioidomycosis
the characteristic ‘ship-pilot’s wheel’ (magniﬁcation × 40) (f).
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 416–425
FIG. 4. Clinical manifestations and laboratory features of paracoccidioidomycosis in a dog. Reproduced from reference de Farias et al. 2011 [75] with
permission of the publisher. Generalized lymphadenomegaly in submandibular lymph node (a); prescapular lymph node (b); inguinal lymph node (c);
popliteal lymph node (d); histological fragment of popliteal lymph node stained with haematoxylin & eosin showing oval structures (e) and stained with
periodic acid–Schiff showing the same poorly stained oval structure surround by neutrophils, macrophages and giant cells (f).
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The disease has been demonstrated in domestic [75] and wild
(armadillos and monkeys) [76,77] animals. Experimental infec-
tion can be obtained in dogs [78,79]. Naturally acquired infec-
tion is also reported in dogs with emaciation,
lymphadenomegaly and hepatosplenomegaly (Fig. 4) [75,80].
Mode of transmission
The epidemiology of the disease indicates a rural predilection,
consistent with most zoonotic infections [34]. The infection, in
both humans and other animals, is transmitted in an airborne
manner by inhalation of conidia present in the environment
[75]. Given that armadillos can harbour the fungus at high
frequencies, this suggests their role as a wild host in the
epidemiological cycle of the disease [76]. In addition, in areas of
endemicity, it has been shown that infected armadillos and
humans share genetically similar strains of P. brasiliensis [81],
which also suggests a zoonotic role for this infection.ConclusionsThe importance of fungal zoonotic or sapronotic infections
has been demonstrated. There is no doubt that these types of
fungi need to be controlled. Control of human exposure to
animal reservoirs can protect susceptible populations and is aClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologycritical component of prevention. From a global public health
prospective, clearly more efforts are needed to raise aware-
ness of the scale of the problem for neglected zoonotic or
sapronotic fungi in order to better deﬁne the burden, distri-
bution, mortality and socio-economic consequences, and also
provide an integrated platform of prevention and control
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